Thursday 29th September 2022 |
Text too small? |
General Capital held its Annual Shareholder Meeting in Auckland yesterday. The meeting was well attended and had a very positive response from shareholders and guests.
The Resolutions were decided by poll. The final results of the voting by poll were:
Resolution 1 Ordinary Resolution
Issue of Shares pursuant to a wholesale capital raising
“That the Shareholders approve (for the purposes of NZX Listing Rule 4.2.1) the issue of up to $5 million of new Shares to such persons (not being Related Parties of GenCap) and in such numbers and proportions as determined by the Board in its absolute discretion and at such price and on such terms as the Board believes is fair and reasonable to GenCap and to all existing Shareholders, but at a price of not less than 5.75 cents per Share.”
The votes were:
For: 63,974,720 (99.87%)
Against: 84,897 (0.13%)
Abstain: 6,996
Resolution 2 Ordinary Resolution
Auditors fees and expenses
“That the Board be authorised to fix the fees and expenses of the auditors of GenCap for the financial year ending 31 March 2023.”
The votes were:
For: 63,919,107 (99.78%)
Against: 143,544 (0.22%)
Abstain: 3,962
Resolution 3 Ordinary Resolution
Election of Director - Paul Zingel
“That Paul Zingel be elected as a director of GenCap.”
The votes were:
For: 62,614,326 (97.81%)
Against: 1,400,510 (2.19%)
Abstain: 51,777
Resolution 4 Ordinary Resolution
Election of Director – Greg James
“That Greg James be elected as a director of GenCap.”
The votes were:
For: 64,002,640 (99.98%)
Against: 12,196 (0.02%)
Abstain: 51,777
Resolution 5 Ordinary Resolution
Re-election of Director - Huei Min (Lyn) Lim
“That Huei Min (Lyn) Lim be re-elected as a director of GenCap.”
The votes were:
For: 63,980,920 (99.93%)
Against: 42,868 (0.07%)
Abstain: 42,825
Resolution 6 Ordinary Resolution
Re-election of Director - Rewi Hamid Bugo
“That Rewi Hamid Bugo be re-elected as a director of GenCap.”
The votes were:
For: 63,977,075 (99.9%)
Against: 45,304 (0.07%)
Abstain: 44,234
Resolution 7 Ordinary Resolution
Increase to Directors’ fee pool
“That the maximum aggregate amount of remuneration payable by GenCap to the Directors (in their capacity as directors, as that term is defined in the NZX Listing Rules) be increased from $300,000 to $600,000 per annum, plus GST (if any), to be paid and allocated among the Directors as the Board from time to time deems appropriate and that any remuneration payable to such Directors may, at the Board’s discretion, in whole or in part, be through an issue of Equity Securities (as that term is defined in the NZX Listing Rules) of GenCap.”
The votes were:
For: 40,552,621 (99.18%)
Against: 333,300 (0.82%)
Abstain: 23,180,692
Meeting Announcements
1) General Finance Ltd.’s Credit rating upgrade
General Finance has had an upgrade of its Credit Rating for BB- with a stable outlook to BB- with a POSITIVE outlook.
Managing Director Brent King said
“This is a reinforcement of the long-term strategy that we have in place. Our strong growth and increases in margins and profits are supporting the credit rating upgrade. We are hopeful of further developments in the next review. We are finding that Depositors are now paying more attention to credit ratings and that non-rated issues are having to pay considerably more for deposits than rated issuers.“
2) Update
General Capital released guidance update on anticipated results to 30/9/2022
30/9/2022 30/9/2021
Total Assets $120m to $125m $82.7m up 45%
Revenue $5.00m to $5.50m $3.30m up 51.5%
Net Profit after Tax $0.90m to $1.05m $357k up 152 %
Summary
The meeting was very successful, and the shareholders expressed their thanks for the significant progress the that had been made.
The shareholders then enjoyed a drink and birthday cake to celebrate the 25th Birthday of General Finance.
For further information contact:
Mr. Brent King
Managing Director
+64 21 632 660
Brent.King@gencap.co.nz
28 September 2022
General Capital Annual Meeting Results and Update - 28092022
No comments yet
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors
December 19th Morning Report
RAD - Radius Care Announces On-market Share Buyback Programme
MCY - New wind farm propels MCY renewables commitment to $1b